InvestorsHub Logo
Followers 44
Posts 3156
Boards Moderated 2
Alias Born 01/18/2016

Re: None

Wednesday, 01/10/2024 6:51:36 AM

Wednesday, January 10, 2024 6:51:36 AM

Post# of 3573
Cassava has developed a radio-isotope version of simufilam: [14C]-Simufilam. The organic molecule is created using Carbon-14 in place of C-12. The resulting molecule may be used as a research aid.
A P1 clinical trial has been logged at clinicaltrials.gov.

All my postings are verified and approved by my dog.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent SAVA News